UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Current Update on Human Papillomavirus-Associated Head and Neck Cancers

Viruses, 2019-10, Vol.11 (10), p.922

Tumban, Ebenezer

2019

Volltextzugriff (PDF)

Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval

Viruses, 2020-12, Vol.13 (1), p.54

Tumban, Ebenezer

2020

Volltextzugriff (PDF)

Virus-like Particle Vaccines and Platforms for Vaccine Development

Viruses, 2023-05, Vol.15 (5), p.1109

2023

Volltextzugriff (PDF)

Potential Applications of Thermophilic Bacteriophages in One Health

International journal of molecular sciences, 2023-05, Vol.24 (9), p.8222

2023

Volltextzugriff (PDF)

Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?

Viruses, 2019-12, Vol.12 (1), p.18

2019

Volltextzugriff (PDF)

Use of Localized Reconstruction to Visualize the Shigella Phage Sf6 Tail Apparatus

Methods in molecular biology (Clifton, N.J.), 2024, Vol.2738, p.215

2024

Volltextzugriff (PDF)

A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2

PloS one, 2011-08, Vol.6 (8), p.e23310

2011

Volltextzugriff (PDF)

VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus

PloS one, 2012-11, Vol.7 (11), p.e49751-e49751

2012

Volltextzugriff (PDF)

Gardasil-9: A global survey of projected efficacy

Antiviral research, 2016-06, Vol.130, p.101-109

2016

Volltextzugriff (PDF)

Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51

Viruses, 2021-06, Vol.13 (6), p.1113

2021

Volltextzugriff (PDF)

Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9

Human vaccines & immunotherapeutics, 2019-08, Vol.15 (7-8), p.1995-2002

2019

Volltextzugriff (PDF)

Zika Virus on a Spreading Spree: what we now know that was unknown in the 1950's

Virology journal, 2016-10, Vol.13 (1), p.165-165, Article 165

2016

Volltextzugriff (PDF)

Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells

Vaccine, 2018-02, Vol.36 (10), p.1256-1264

2018

Volltextzugriff (PDF)

Bacteriophage Qβ virus-like particles displaying Chikungunya virus B-cell epitopes elicit high-titer E2 protein antibodies but fail to neutralize a Thailand strain of Chikungunya virus

Vaccine, 2020-03, Vol.38 (11), p.2542-2550

2020

Volltextzugriff (PDF)

Novel expression of coat proteins from thermophilic bacteriophage ΦIN93 and evaluation for assembly into virus-like particles

Protein expression and purification, 2021-11, Vol.187, p.105932-105932, Article 105932

2021

Volltextzugriff (PDF)

A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9

Antiviral research, 2017-11, Vol.147, p.116-123

2017

Volltextzugriff (PDF)

Second-generation prophylactic HPV vaccines: successes and challenges

Expert review of vaccines, 2014-02, Vol.13 (2), p.247-255

2014

Volltextzugriff (PDF)

Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer

Antiviral research, 2019-06, Vol.166, p.56-65

2019

Volltextzugriff (PDF)

A universal virus-like particle-based vaccine for human papillomavirus: Longevity of protection and role of endogenous and exogenous adjuvants

Vaccine, 2013-09, Vol.31 (41), p.4647-4654

2013

Volltextzugriff (PDF)

Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus

Molecular pharmaceutics, 2016-05, Vol.13 (5), p.1646-1655

2016

Volltextzugriff (PDF)

The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine

Biotechnology and bioengineering, 2014-12, Vol.111 (12), p.2398-2406

2014

Volltextzugriff (PDF)

Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2

Vaccine, 2015-06, Vol.33 (29), p.3346-3353

2015

Volltextzugriff (PDF)

Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature

Papillomavirus research, 2017-06, Vol.3, p.116-120

2017

Volltextzugriff (PDF)

Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing

Vaccine, 2014-07, Vol.32 (34), p.4267-4274

2014

Volltextzugriff (PDF)

A Novel Candidate MS2 Phage VLP Vaccine Displaying a tandem HPV L2 Peptide offers Similar Protection in Mice to Gardasil-9

Antiviral research, 2017-09, Vol.147, p.116-123

2017

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(32)
Dissertationen
(1)

Sprache

Englisch
(33)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(26)
Animals
(19)
Vaccines
(16)
Virology
(16)
Virus-Like Particles
(16)
Humans
(15)
Human Papillomavirus
(13)
Papillomavirus Vaccines - Immunology
(13)
Antibodies
(12)
Mice
(12)
Proteins
(12)
Antibodies, Viral - Blood
(11)
Cervical Cancer
(11)
Female
(11)
Vaccines, Virus-Like Particle - Immunology
(11)
Mice, Inbred Balb C
(10)
Papillomavirus Infections - Prevention & Control
(9)
Viruses
(9)
Capsid Proteins - Immunology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Current Update on Human Papillomavirus-Associated Head and Neck Cancers

Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval

Virus-like Particle Vaccines and Platforms for Vaccine Development

Potential Applications of Thermophilic Bacteriophages in One Health

Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?

Use of Localized Reconstruction to Visualize the Shigella Phage Sf6 Tail Apparatus

A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2

VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus

Gardasil-9: A global survey of projected efficacy

Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51

Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9

Zika Virus on a Spreading Spree: what we now know that was unknown in the 1950's

Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells

Bacteriophage Qβ virus-like particles displaying Chikungunya virus B-cell epitopes elicit high-titer E2 protein antibodies but fail to neutralize a Thailand strain of Chikungunya virus

Novel expression of coat proteins from thermophilic bacteriophage ΦIN93 and evaluation for assembly into virus-like particles

A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9

Second-generation prophylactic HPV vaccines: successes and challenges

Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer

A universal virus-like particle-based vaccine for human papillomavirus: Longevity of protection and role of endogenous and exogenous adjuvants

Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus

The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine

Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2

Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature

Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing

A Novel Candidate MS2 Phage VLP Vaccine Displaying a tandem HPV L2 Peptide offers Similar Protection in Mice to Gardasil-9

Suchergebnisse filtern